GLP-1 & Metabolic

Survodutide

SKU NA-018CAS 2503377-22-2MW 4316.9
98.8% HPLCThird-party testedRUO · Research use only
RUOThis product is sold for laboratory research use only. It is not a drug or supplement and is not for human or veterinary consumption, diagnostic or therapeutic use.

$61.99

HPLC verifiedPurity confirmed per lot
COA includedLot-specific certificate
Cold-chainShipped 2-8°C with packs
Lot traceableDocumented to dispatch
Description

Survodutide is a GLP-1 and glucagon receptor dual-agonist research peptide, supplied lyophilized with lot-specific HPLC documentation.

Specifications
CompoundSurvodutide
ClassificationGLP-1 / glucagon dual agonist
CAS number2503377-22-2
Molecular formulaC198H312N50O59
Molecular weight4316.9 g/mol
Purity98.8% by RP-HPLC (area %)
Physical formLyophilized powder
AppearanceWhite solid
ReconstitutionBacteriostatic water
Lab documentation

Each production lot is released against an analytical specification and ships with the corresponding Certificate of Analysis.

Certificate of AnalysisLot SVD-2406-A
MethodRP-HPLC / UV 214 nm
Purity (area %)98.8%
IdentityESI-MS confirmed
AppearanceWhite solid
Storage & handling

Storage. Store lyophilized material at -20°C protected from light and moisture for long-term stability. After reconstitution, keep at 2-8°C and use within the documented in-use window.

Handling. Allow sealed vials to equilibrate to room temperature before opening to limit condensation. Reconstitute with the listed diluent using standard aseptic laboratory technique. Avoid repeated freeze-thaw cycles.

Safety. Handle as a laboratory research chemical. Wear appropriate PPE and follow your institution's chemical-handling and waste-disposal procedures.

Shipping

Dispatch. In-stock orders are processed on business days and shipped with temperature-controlled packaging and gel packs to preserve material integrity in transit.

Tracking. A tracking reference is issued at dispatch. Lab accounts can consolidate shipments and arrange standing orders.

Eligibility. Orders are accepted from researchers, resellers and institutions for laboratory research use only.

Selected research

Literature referencing this compound.

Publications relevant to this molecule, provided for research reference. Inclusion does not imply an approved use or any claim about the products sold here.

Phase 2 RCT
Lancet Diabetes Endocrinol. 2024;12(3):162–173
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a phase 2 trial
le Roux CW, Steen O, Lucas KJ, et al.
Phase 2 RCT
N Engl J Med. 2024;391(4):311–319
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
Sanyal AJ, Bedossa P, Fraessdorf M, et al.